Key Highlights

  • Modular Medical shares closed up 8% at $3.68.
  • The company secured a contract with a national U.S. pharmacy benefit manager for its Pivot tubeless insulin patch pump.
  • The deal expands reimbursement and patient-access infrastructure ahead of planned commercial launch.
  • It follows recent FDA clearance for software enhancements adding bolus dosing customization and user-interface upgrades.

Modular Medical, Inc. (NASDAQ: MODD) shares closed up 8% at $3.68 after the company secured a contract with a national U.S. pharmacy benefit manager for its Pivot tubeless insulin patch pump.

What Happened

The contract expands reimbursement and patient-access infrastructure ahead of the company's planned commercial launch, following recent FDA clearance for software enhancements that added bolus dosing customization and user-interface upgrades.

Market Reaction

Shares rose as investors responded to the expanded reimbursement infrastructure, a meaningful step in supporting patient access ahead of Pivot's commercial launch.

Outlook

The planned commercial launch of the Pivot insulin patch pump, now supported by expanded reimbursement infrastructure, represents the next major milestone for Modular Medical.